Elicio Therapeutics hosts expert event on ELI-002 7P for pancreatic cancer

ELTX•2026-11-04

Elicio Therapeutics will host a virtual expert event on November 11, 2026, to discuss Phase 2 findings for camupepimut (ELI-002 7P) and its late-stage development for metastatic pancreatic cancer.

Elicio Therapeutics hosts expert event on ELI-002 7P for pancreatic cancer

1. Virtual event

Related News

ABM to participate in RW Baird Global Industrial Conference

Southwest Gas Q3 profit beats estimates on rate hikes, lower interest expense

NewcelX agrees to sell Mazindol portfolio to REA Holdings

Afya answers shareholder questions ahead of merger vote

Argus Research raises Fiserv to buy from hold